Zhejiang Medicines & Heal · 66-66 · CHINA

For Zhejiang Medicines & Heal · 66-66 · CHINA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is CHINA; product is Doxorubicin HCl | Daunorubicin HCl | Mitomycin; product code is 56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf | 56 H - S 25 Daunorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf | 56 H - S 45 Mitomycin (Antitumor), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 7 Tianmushan Road , Hangzhou, Zhejiang CHINA, verified against its source on 2026-09-16.

What the source says

Zhejiang Medicines & Heal Date Published : 09/30/2009 7 Tianmushan Road , Hangzhou, Zhejiang CHINA 56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/25/2019 Desc: Doxorubicin HCl Notes: 10/10/2000 56 H - S 25 Daunorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/25/2019 Desc: Daunorubicin HCl Notes: 10/10/2000 56 H - S 45 Mitomycin (Antitumor), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/25/2019 Desc: Mitomycin Notes: J0/10/2000

— accessdata.fda.gov, retrieved 2026-09-15

Source

• accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified against source: 2026-09-16. Due for re-check by 2026-11-15. This page as Markdown · OKF bundle · full dataset as JSON.